Last reviewed · How we verify
MULTIGENE SCREENING FOR SINGLE SNPS — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
MULTIGENE SCREENING FOR SINGLE SNPS (MULTIGENE SCREENING FOR SINGLE SNPS) — Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| MULTIGENE SCREENING FOR SINGLE SNPS TARGET | MULTIGENE SCREENING FOR SINGLE SNPS | Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- MULTIGENE SCREENING FOR SINGLE SNPS CI watch — RSS
- MULTIGENE SCREENING FOR SINGLE SNPS CI watch — Atom
- MULTIGENE SCREENING FOR SINGLE SNPS CI watch — JSON
- MULTIGENE SCREENING FOR SINGLE SNPS alone — RSS
Cite this brief
Drug Landscape (2026). MULTIGENE SCREENING FOR SINGLE SNPS — Competitive Intelligence Brief. https://druglandscape.com/ci/multigene-screening-for-single-snps. Accessed 2026-05-13.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab